financetom
Business
financetom
/
Business
/
Novartis, Monte Rosa strike $5.7 billion drug development deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Novartis, Monte Rosa strike $5.7 billion drug development deal
Sep 15, 2025 4:21 AM

Sept 15 (Reuters) - Swiss drugmaker Novartis

and drug developer Monte Rosa Therapeutics ( GLUE ) signed a

licensing deal worth up to $5.7 billion on Monday to develop

drugs for immune-mediated diseases.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved